Bridgetech Holdings International, Inc., a company focused on maximizing the potential of emerging healthcare products and services in China and the U.S., today announced the formation of its Science Advisory Board (SAB). The Bridgetech SAB is made up of leading oncology experts from both the
United States and China. The company will rely on their advice and direction to
introduce current and emerging science and technology to China.